Progress of skeletal muscle mass evaluation, diagnosis and treatment of sarcopenia in patients with liver disease
10.3760/cma.j.cn113884-20200304-00112
- VernacularTitle:肝病患者肌肉减少症骨骼肌测量及诊治研究进展
- Author:
Jiancun HOU
1
;
Yamin ZHANG
Author Information
1. 天津市第一中心医院肝胆外科 300192
- From:
Chinese Journal of Hepatobiliary Surgery
2020;26(11):873-877
- CountryChina
- Language:Chinese
-
Abstract:
Liver disease-associated sarcopenia is a type of secondary sarcopenia, which is a common muscle abnormality in patients with liver cirrhosis and is often ignored by doctors. Patients with chronic liver disease often have reduced appetite, insufficient protein intake, indigestion caused by portal hypertension, and high metabolism, which accelerate the wasting of skeletal muscle. At present, sarcopenia is recognized as a risk factor which is closely related with postoperative complications and morbidity in liver surgery, and also affects the quality of life of patients with liver disease. This article reviews the current diagnosis and treatment options of sarcopenia and the impact of sarcopenia on the prognosis of liver disease, thus to provide references in clinical practice.
